Our objective was to assess the prognostic value of symptom typicality in patients without obstructive coronary artery disease (CAD), determined by coronary computed tomographic angiography (CCTA). We identified 4215 patients without prior history of CAD and without obstructive CAD (<50% CCTA stenosis). CAD severity was categorized as nonobstructive (1%-49%) and none (0%). Based upon the Diamond-Forrester criteria for angina pectoris, symptom typicality was classified as asymptomatic, nonanginal, atypical, and typical. Multivariable Cox proportional hazards models were used to assess the risk of major adverse cardiac events (MACE), comprising allcause mortality, myocardial infarction, unstable angina, and late revascularization, according to symptom typicality. Mean patient age was 57.0 AE12.0 years (54.9% male). During a median follow-up of 5.3 years (interquartile range, 4.6-5.9 years), MACE were reported in 312 (7.4%) patients. Among patients with nonobstructive CAD, there was an association between symptom typicality and MACE (P for interaction = 0.05), driven by increased risk of MACE among those with typical angina and nonobstructive CAD (hazard ratio: 1.62, 95% confidence interval:
1.06-2.48, P = 0.03). No consistent relationship was found between symptom typicality and MACE among patients without any CAD (hazard ratio: 0.73, 95% confidence interval: 0.34-1.57, P = 0.08). In the CONFIRM registry, patients who presented with concomitant typical angina and nonobstructive CAD had a higher rate of MACE than did asymptomatic patients with nonobstructive CAD. However, the presence of typical angina did not appear to portend worse prognosis in patients with no CAD. 
| INTRODUCTION
Coronary computed tomographic angiography (CCTA) is a noninvasive imaging modality commonly used in the evaluation of patients with suspected coronary artery disease (CAD). Favorable test characteristics include high diagnostic performance for ruling out obstructive CAD. [1] [2] [3] CCTA is also useful for the detection of nonobstructive CAD, a condition associated with an increased risk of adverse cardiovascular outcomes. 4 The presence of nonobstructive CAD is particularly important given the observation that the majority of plaque ruptures implicated in acute coronary syndrome arise from nonobstructive plaques. [5] [6] [7] Among patients undergoing evaluation for suspected CAD, chest pain is a frequent symptom that may present a clinical and therapeutic challenge. 8 Although the prognosis of nonobstructive CAD among patients with chest pain had once been considered to be benign, several recent studies using invasive angiography have elucidated the adverse prognosis associated with nonobstructive CAD. 9,10 Previous investigations have shown that among patients with stable chest pain, typical angina pectoris provides valuable diagnostic information for identification of obstructive CAD by invasive coronary angiography. 11 In addition, typical angina is associated with higher prevalence of obstructive CAD on CCTA compared with those without typical angina. 12 However, the prognostic impact of symptom typicality in patients with nonobstructive CAD by CCTA remains unclear. In the present study, we sought to determine the extent to which symptom typicality adds prognostic information in patients without obstructive CAD by CCTA.
| METHODS

| Study population
The rationale and design of the Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter (CONFIRM) registry has been previously described. 13 For the purposes of this study, we used data from the CONFIRM long-term follow-up registry that included participants with ≥3 years of follow-up. Enrolled were 17 181 patients who underwent CCTA at 17 centers in 9 countries within North America, Europe, and Asia between December 2002 and May 2011. Patients were deemed suitable for study inclusion if they were age ≥ 18 years, had undergone evaluation by CCTA scanner with ≥64 detector rows, and presented with an interpretable CCTA.
Patients with nonevaluable segments were not included in this analysis. Patients were excluded according to the following criteria: known prior CAD at the time of CCTA, as defined by prior myocardial infarction (MI) or coronary revascularization, such as coronary artery bypass graft surgery and percutaneous coronary intervention (n = 2248); adverse events on the day of CCTA (n = 50); obstructive CAD (n = 4644); missing information for baseline factors, including age or sex (n = 30) as well as symptom typicality (n = 1755); severity of CAD (n = 434); missing information for major adverse cardiac events (MACE; n = 3729); and early revascularization <90 days from index CCTA (n = 322).
Each of the study centers' institutional review boards approved the study protocol, and all study participants provided written informed consent. Tomography (SCCT). 15, 16 The definition of coronary atherosclerosis was any lesion ≥1 mm 2 that existed either within the lumen of the coronary artery or adjacent to the coronary artery lumen that could be distinguished from surrounding pericardial tissue, epicardial fat, or the artery lumen itself. CAD was defined as the presence of any plaque in the coronary artery. Nonobstructive CAD was defined as coronary artery segment plaque with a luminal diameter stenosis >0% and < 50%. Patients with 0% stenosis or a normal CCTA were considered to have no CAD. For further reliability and accuracy, all identified lesions were interrogated via numerous methods such as maximumintensity-projection and multiplanar-reconstruction techniques along several longitudinal axes and in the transverse plane.
| Clinical characteristics and chest pain categorization
| Study outcome
The primary outcome was a composite of MACE including all-cause mortality (ACM), nonfatal MI, unstable angina, and late target-vessel revascularization (>90 days). Specific causes of death were not recorded in the CONFIRM registry. Trained personnel from each site adjudicated ACM by direct interview with physicians or by querying national medical databases. Other events such as MI and late target revascularization were collected via a combination of direct questioning of patients using a scripted interview and examination of the patients' medical records as previously described. 13 
| Statistical methods
Continuous variables are reported as mean AESD, and categorical variables are presented as counts with percentages. We compared differences between continuous variables using a Student t test.
Differences between categorical variables were compared with a χ 2 or
Fisher exact test, as appropriate. Incidence of MACE per 1000 person-years was estimated by dividing the number of MACE by the absolute number of person-years at risk. We evaluated the relationship between symptom typicality and MACE according to the severity of CAD using the Kaplan-Meier method with log-rank tests for equality. Unadjusted and multivariable Cox regression models were used to calculate hazard ratios (HR) with 95% confidence intervals (CI) and identify associations between symptom typicality and MACE in patients without obstructive CAD, as well as for comparisons between nonobstructive CAD and no CAD. Candidate variables were selected for consideration in multivariable models based on a priori clinical knowledge. In the first model (Model 1), variables with significant univariate associations (P < 0.05) between both the predictor of interest 
| RESULTS
Of 4215 patients included in the study, 1848 (43.8%), 498 (11.8%), 1497 (35.5%), and 372 (8.8%) were asymptomatic or had nonanginal, atypical, and typical angina, respectively. Overall, the mean age of the cohort was 57.0 AE12.0 years and 54.9% were male (Table 1) . Participants with typical angina had a higher prevalence of DM, whereas those with nonanginal symptoms were older, more likely to smoke, and had a higher prevalence of HTN and family history of CAD (P < 0.001 for all). The asymptomatic group was predominantly male (P < 0.001). We performed a series of sensitivity analyses to evaluate the consistency of our main findings. First, we performed an analysis adjusted for estimated Framingham risk score. Our results remained consistent after adjustment for Framingham risk score, with typical symptoms being associated with a HR of 1.74 (95% CI: 1.15-2.63) for MACE 
| DISCUSSION
In a large prospective, international, multicenter registry, we observed an independent association between typical angina pectoris and increased risk of MACE among patients with nonobstructive CAD determined by CCTA. In particular, typical angina among those with nonobstructive CAD was associated with a 1.6-fold increase in the risk of MACE, and may therefore portend worse prognosis as compared with asymptomatic patients with nonobstructive CAD. These findings, however, were largely driven by late revascularization. Conversely, we found no relationship between symptom typicality and MACE in patients with a normal CCTA. These findings underscore the prognostic significance of typical angina in patients diagnosed as having CCTA-visualized nonobstructive CAD in a routine clinical setting.
The current study observations are fitting with some, 9, 10 but not all, [17] [18] [19] prior observations. Previously, several studies documented that chest pain without obstructive CAD is associated with low rates of adverse cardiovascular outcomes. However, these studies were limited by factors such as small sample sizes, limited endpoint ascertainment, and cohorts that may not reflect contemporary clinical practice. [17] [18] [19] More recently, the Women's Ischemia Syndrome Evaluation (WISE) study reported that women with symptoms and signs suggestive of ischemia but without obstructive CAD are at increased risk of cardiovascular events compared with asymptomatic women, emphasizing that these women should not be considered low-risk. 9 Although the WISE study was limited to women, our study findings in a population of both men and women enrolled in a contemporary registry extend the findings of WISE to a broader population. Importantly, our main findings were consistent irrespective of sex, without evidence of effect modification by sex. These findings are in keeping with a previous analysis from the CONFIRM registry demonstrating similar prognosis among men and women with nonobstructive CAD matched for age, symptoms, and risk factors. 20 The present study findings are also in keeping with those with of to improve the prediction of lesions that cause ischemia. 21 In a substudy of the Analysis of Coronary Blood Flow Using CT Angiography:
Next Steps (NXT) trial, Gaur et al.. 22 the presence and extent of nonobstructive plaques enhanced mortality risk prediction. Our study corroborates and expands the results of the latter study. We have shown that beyond plaque burden, the presence of symptoms influences prognosis in patients with nonobstructive CAD. Our data support the notion that stratification by symptoms is important in both the decision to refer to CCTA and the clinical interpretation of CCTA.
| Study limitations
Our study design is strengthened by the use of a large, contemporary international registry that reflects real-world patients. However, the limitations of our study design are noteworthy. Given the observational nature of this registry, our study may have been prone to potential biases such as heterogeneity in the population, interobserver and multisite variability in CCTA interpretation, and residual confounding. However, in an effort to minimize such biases, standardized data definitions were prospectively utilized, and only experienced CCTA centers with trained experts participated. 13 Given our study design, we were unable to consider the effect of cardiac medications that may have influenced symptom typicality. The CONFIRM study design did not allow for determination of cardiac mortality or further understanding of causes of death in patients with no CAD. However, prior studies have shown that use of cause-specific death can be inaccurate due to misclassification or misreporting of death, which can lead to an overestimation of cardiac deaths. 27 There were few "hard" events in this study, and thus our findings were largely driven by late revascularization and may reflect the practice that patients with typical angina were more likely to undergo late revascularization than were patients without symptoms.
Although the presence of symptoms was prospectively determined at the time of CCTA, information regarding the typicality of symptoms was assessed at select enrollment sites and missing in 1755 patients. Further, our null findings with respect to symptom typicality in patients without any CAD raise a question of whether there was sufficient power in this group. However, a post hoc power analysis demonstrated 80% power to detect the observed effect estimates in both unadjusted and adjusted models, with the exception of typical angina, which was slightly underpowered at 58% in the unadjusted model.
| CONCLUSION
In this prospective, international registry of patients undergoing CCTA, we observed an increased risk of MACE including late revascularization among patients who have concomitant typical angina and nonobstructive CAD, as compared with asymptomatic patients with nonobstructive CAD. In contrast, symptoms were not associated with a worse prognosis in patients without CCTA-visualized CAD.
Conflicts of interest
Dr. Min serves on the scientific advisory board of Arineta, has ownership in MDDX, and has a research agreement with GE Healthcare.
